New Key Statistics Module, Z-Score and F-Score
NAS:CYTK Key Ratios
Market Cap $ M | 6,183.01 |
Enterprise Value $ M | 5,752.86 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 57.12 |
Price/Sales | 1,695.19 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 3.00 |
EPS (TTM) $ | -5.37 |
Beneish M-Score | -3.66 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -28.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.17 |
EV-to-EBITDA | -12.52 |
PEG | -- |
Shares Outstanding M | 117.66 |
Net Margin (%) | -17,398.82 |
Operating Margin % | -16,148.37 |
Pre-tax Margin (%) | -17,398.82 |
Quick Ratio | 10.39 |
Current Ratio | 10.39 |
ROA % (ttm) | -58.30 |
ROE % (ttm) | -- |
ROIC % (ttm) | -171.11 |
Dividend Yield % | -- |
Altman Z-Score | 0.11 |
CYTK Number of Guru Trades
CYTK Volume of Guru Trades
Gurus Latest Trades with NAS:CYTK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CYTK is held by these investors
Total 3
Cytokinetics Inc Insider Transactions
No Available Data
News about NAS:CYTK
Total 0- 1